Patent ID: 11944632
Assignee: SAVA HEALTHCARE LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A pharmaceutical formulation comprising:
a micronized Sodium 3,5-dichloro-2,4,6-trioxo-1,3,5-triazinan-1-ide (NaDCC) having a particle size in the range of 3 μm to 7 μm;
a first lactose having a particle size in the range of 15 μm to 120 μm;
a second lactose having a particle size in the range of 1 μm to 70 μm; and
at least one excipient;, wherein the weight ratio of the first lactose to the second lactose is in the range of 4:1 to 10:1;, wherein said first lactose and second lactose are adsorbed on said micronized Sodium 3,5-dichloro-2,4,6-trioxo-1,3,5-triazinan-1-ide (NaDCC); and, wherein said pharmaceutical formulation is in the form of an inhalable dry powder.